[go: up one dir, main page]

LV10270A - 2-[(2-Piridinil)metilsulfinil-(vai sulfonil)]-1H-benzimidazol-1-ila atvasinajumi to iegusanas panemiens farmaceitiska kompozicija uz to bazes pielietojums - Google Patents

2-[(2-Piridinil)metilsulfinil-(vai sulfonil)]-1H-benzimidazol-1-ila atvasinajumi to iegusanas panemiens farmaceitiska kompozicija uz to bazes pielietojums

Info

Publication number
LV10270A
LV10270A LV930856A LV930856A LV10270A LV 10270 A LV10270 A LV 10270A LV 930856 A LV930856 A LV 930856A LV 930856 A LV930856 A LV 930856A LV 10270 A LV10270 A LV 10270A
Authority
LV
Latvia
Prior art keywords
methylsulfinyl
benzimidazol
pyridinyl
sulfonyl
base
Prior art date
Application number
LV930856A
Other languages
English (en)
Other versions
LV10270B (en
Inventor
Tomas Boerje Alminger
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Haekan Sigurd Larsson
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of LV10270A publication Critical patent/LV10270A/lv
Publication of LV10270B publication Critical patent/LV10270B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
LVP-93-856A 1985-10-29 1993-06-30 Novel pharmacological compounds LV10270B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8505112A SE8505112D0 (sv) 1985-10-29 1985-10-29 Novel pharmacological compounds
PCT/SE1986/000493 WO1987002668A1 (en) 1985-10-29 1986-10-28 Novel pharmacological compounds

Publications (2)

Publication Number Publication Date
LV10270A true LV10270A (lv) 1994-10-20
LV10270B LV10270B (en) 1995-04-20

Family

ID=20361960

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-856A LV10270B (en) 1985-10-29 1993-06-30 Novel pharmacological compounds

Country Status (31)

Country Link
US (1) US5021433A (lv)
EP (2) EP0221041A3 (lv)
JP (2) JPH0780874B2 (lv)
KR (1) KR950009858B1 (lv)
CN (1) CN1022487C (lv)
AT (1) ATE79619T1 (lv)
AU (1) AU598491B2 (lv)
CS (1) CS272767B2 (lv)
DD (1) DD252375A5 (lv)
DE (1) DE3686483T2 (lv)
DK (1) DK320587D0 (lv)
EG (1) EG17753A (lv)
ES (1) ES2051696T3 (lv)
FI (1) FI91151C (lv)
GR (1) GR3006177T3 (lv)
HU (1) HU198474B (lv)
IE (1) IE59167B1 (lv)
IL (1) IL80437A0 (lv)
IS (1) IS1564B (lv)
JO (1) JO1502B1 (lv)
LT (1) LTIP1681A (lv)
LV (1) LV10270B (lv)
MY (1) MY101791A (lv)
NO (1) NO171365C (lv)
NZ (1) NZ218028A (lv)
PH (1) PH25319A (lv)
PL (1) PL150240B1 (lv)
PT (1) PT83647B (lv)
SE (1) SE8505112D0 (lv)
WO (1) WO1987002668A1 (lv)
ZA (1) ZA867716B (lv)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222495A (en) * 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
US5175286A (en) * 1988-09-20 1992-12-29 Hisamitsu Pharmaceutical Co., Inc. Dibenz[b,e]oxepin derivatives
EG19302A (en) * 1988-12-22 1994-11-30 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
CA2083606C (en) * 1990-06-20 2001-08-21 Arne Elof Brandstrom Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
WO1995032957A1 (en) * 1994-05-27 1995-12-07 Astra Aktiebolag Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
NZ510180A (en) * 1998-08-10 2002-11-26 Univ California Prodrugs of the pyridyl-methylsulphonyl-benzimidazole type proton pump inhibitors
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
EP1334971A4 (en) * 2000-10-12 2004-05-12 Takeda Chemical Industries Ltd BENZIMIDAZOLE COMPOUNDS, METHOD FOR THE PRODUCTION AND USE THEREOF
WO2003027098A1 (fr) * 2001-09-25 2003-04-03 Takeda Chemical Industries, Ltd. Compose de benzymidazole, procede de production et d'utilisation de celui-ci
US7410981B2 (en) * 2002-06-14 2008-08-12 Takeda Pharmaceutical Company Limited Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
MXPA05000657A (es) * 2002-07-19 2005-08-19 Winston Pharmaceuticals Llc Profarmacos de los inhibidores de bomba de protones.
JP4634144B2 (ja) 2002-08-01 2011-02-16 ニコックス エスエー ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
EP2112920B1 (en) * 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US20060241037A1 (en) * 2003-10-03 2006-10-26 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
BRPI0507784A (pt) * 2004-02-18 2007-07-17 Allergan Inc métodos e composições para a administração de pró-fármacos de inibidores da bomba de prótons
US20070161679A1 (en) * 2004-02-18 2007-07-12 Allergan, Inc. Method and compositions for the intravenous administration of compounds related to proton pump inhibitors
MXPA06011820A (es) * 2004-04-16 2006-12-15 Santarus Inc Combinacion de inhibidor de bomba de proton, agente regulador del ph y agente procinetico.
ATE437869T1 (de) 2004-04-28 2009-08-15 Hetero Drugs Ltd Verfahren zur herstellung von pyridinylmethyl-1h- benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere
PT1748998E (pt) 2004-05-28 2010-03-24 Hetero Drugs Ltd Novo processo de síntese estereoselectiva de sulfóxidos de benzimidazol
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
EP2007360B1 (en) * 2006-04-03 2014-11-26 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
CA2667682A1 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
WO2009105568A1 (en) 2008-02-20 2009-08-27 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
EP2521545B1 (en) * 2010-01-07 2019-11-27 Alkermes Pharma Ireland Limited Prodrugs of heteroaromatic compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (lv) * 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA856671B (en) * 1984-09-24 1986-04-30 Upjohn Co N-substituted derivatives of 2-(pyridylaklenesulfinyl)benzimidazoles as gastric antisecretory agents
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives

Also Published As

Publication number Publication date
DD252375A5 (de) 1987-12-16
LTIP1681A (en) 1995-09-25
CN1022487C (zh) 1993-10-20
FI872864A0 (fi) 1987-06-29
CS782686A2 (en) 1990-05-14
NZ218028A (en) 1990-02-26
KR870700620A (ko) 1987-12-30
MY101791A (en) 1992-01-31
IE862805L (en) 1987-04-29
GR3006177T3 (lv) 1993-06-21
EP0233284A1 (en) 1987-08-26
FI91151C (sv) 1994-05-25
JPS63501151A (ja) 1988-04-28
AU598491B2 (en) 1990-06-28
ATE79619T1 (de) 1992-09-15
KR950009858B1 (ko) 1995-08-29
JPH0826014B2 (ja) 1996-03-13
JO1502B1 (en) 1989-01-25
EP0233284B1 (en) 1992-08-19
NO872686L (no) 1987-06-26
IS3156A7 (is) 1987-04-30
ZA867716B (en) 1987-05-27
PT83647A (en) 1986-11-01
HU198474B (en) 1989-10-30
IS1564B (is) 1994-12-13
DE3686483T2 (de) 1993-02-04
CS272767B2 (en) 1991-02-12
PL262105A1 (en) 1988-08-18
PT83647B (pt) 1989-05-31
NO872686D0 (no) 1987-06-26
IL80437A0 (en) 1987-01-30
DE3686483D1 (de) 1992-09-24
AU6542986A (en) 1987-05-19
PH25319A (lv) 1991-04-30
EP0221041A3 (en) 1987-10-28
PL150240B1 (en) 1990-05-31
SE8505112D0 (sv) 1985-10-29
US5021433A (en) 1991-06-04
EG17753A (en) 1991-12-30
JPH0780874B2 (ja) 1995-08-30
DK320587A (da) 1987-06-24
FI872864A (fi) 1987-06-29
DK320587D0 (da) 1987-06-24
HUT43843A (en) 1987-12-28
EP0221041A2 (en) 1987-05-06
LV10270B (en) 1995-04-20
JPH07188216A (ja) 1995-07-25
CN86107595A (zh) 1987-07-08
NO171365B (no) 1992-11-23
WO1987002668A1 (en) 1987-05-07
ES2051696T3 (es) 1994-07-01
IE59167B1 (en) 1994-01-12
NO171365C (no) 1993-03-03
FI91151B (fi) 1994-02-15

Similar Documents

Publication Publication Date Title
LV10270A (lv) 2-[(2-Piridinil)metilsulfinil-(vai sulfonil)]-1H-benzimidazol-1-ila atvasinajumi to iegusanas panemiens farmaceitiska kompozicija uz to bazes pielietojums
SE8700499L (sv) Nya farmakologiskt aktiva foreningar
SE8804629D0 (sv) New therapeutically active compounds
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
SE8404065D0 (sv) Novel biologically active compounds
IT1224405B (it) Composti attivi sul sistema cardiovascolare
SE8600658D0 (sv) Novel composition of matter
DK122191A (da) Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
ATE123497T1 (de) Substituierte pyridin-verbindungen, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
IT1224404B (it) Composti attivi sul sistema cardiovascolare
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)